Hualien Tzu Chi General Hospital
14
2
2
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
7.1%
1 terminated/withdrawn out of 14 trials
80.0%
-6.5% vs industry average
7%
1 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Prospective, Randomized, Multi-Center Comparative Study on Topical Probiotics in Diabetic Foot Ulcers
Role: collaborator
Cognitive-behavioral Therapy for the Diseases Associated With Esophageal-brain-gut Axis Communication Abnormalities.
Role: lead
Telemedicine Wounds
Role: collaborator
Neuroregulators for the Treatment of Diseases Associated With Esophageal-brain-gut Axis Communication Abnormalities.
Role: lead
A Short Regimen for Rifampicin-resistant Isoniazid-susceptible TB
Role: collaborator
Chlorhexidine to Prevent Catheter-related Urinary Tract Infection
Role: collaborator
Intravesical Platelet-rich Plasma Injection in Patients With Interstitial Cystitis/Bladder-A Retrospective Study
Role: lead
Validation of the Blood Pressure Monitoring Function
Role: collaborator
Efficacy and Safety of Low Energy Shock Wave Plus BotulinumToxin A in Treating Patients With Interstitial Cystitis
Role: collaborator
Using Oral Valacyclovir to Treat Patients With Refractory IC/BPS
Role: collaborator
Comparing Re-TACE Versus SABR for Post-prior-TACE Incompletely Regressed HCC: a Randomized Controlled Trial (TASABR)
Role: collaborator
Imatinib for Cytomegalovirus Prophylaxis and Treatment After Allogeneic Hematopoietic Stem Cell Transplantation
Role: collaborator
Intergenerational mHealth Diabetes Program OPPORTUNITIES PROGRAM IN TAIWAN
Role: collaborator
Prognostic Value of Peak Lactate During Cardiopulmonary Bypass in Adult Cardiac Surgeries
Role: lead
All 14 trials loaded